David Rowe

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.

Martin Rowe, David Rowe, Christopher D. Gregory et al. · The EMBO Journal · 1987 · 723 citations · Full text

Lymphoid Neoplasia, Lymphocyte Development, Lymphoma Cells +6

Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos.

Paul J. Farrell, David Rowe, Cliona M. Rooney et al. · The EMBO Journal · 1989 · 328 citations

Transcriptional Regulation, Signal Transduction, Signaling Pathway +6

Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders

David Rowe, L. Qu, Jorgé Reyes et al. · Journal of Clinical Microbiology · 1997 · 305 citations · Full text

Prevalence of Neutralizing Antibodies to Adenoviral Serotypes 5 and 35 in the Adult Populations of The Gambia, South Africa, and the United States

Edward Nwanegbo, Eftyhia Vardas, Wentao Gao et al. · Clinical and Vaccine Immunology · 2004 · 265 citations · Full text

Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes

L. Qu, David Rowe · Journal of Virology · 1992 · 249 citations · Full text

Restricted Expression Latency, Epstein-barr Virus, Neurovirology +14